about
Pathogenesis of Type 2 Epithelial to Mesenchymal Transition (EMT) in Renal and Hepatic FibrosisTGF-β/Smad signaling in renal fibrosisMolecular aspects of development and regulation of endometriosisMicroRNAs in Diabetic Kidney DiseaseEpigenetics of progression of chronic kidney disease: fact or fantasy?The Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the LungRole of bone morphogenetic protein-7 in renal fibrosisMolecular mechanism of smurf2 in regulating the expression of SnoN in diabetic nephropathy.Estrogen preserves split renal function in a chronic complete unilateral ureteral obstruction animal modelCellular mechanisms of tissue fibrosis. 8. Current and future drug targets in fibrosis: focus on Rho GTPase-regulated gene transcription.Integrin-mediated type II TGF-β receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling.Pharmacological and genetic depletion of fibrinogen protects from kidney fibrosis.Augmenter of liver regeneration ameliorates renal fibrosis in rats with obstructive nephropathy.L-Endoglin overexpression increases renal fibrosis after unilateral ureteral obstruction.Novel RNA-binding protein P311 binds eukaryotic translation initiation factor 3 subunit b (eIF3b) to promote translation of transforming growth factor β1-3 (TGF-β1-3).Characterization of microRNA expression profiles in Leishmania-infected human phagocytes.MicroRNAs in renal fibrosis.MicroRNA MiR-199a-5p regulates smooth muscle cell proliferation and morphology by targeting WNT2 signaling pathway.Differential expression and therapeutic efficacy of microRNA-346 in diabetic nephropathy miceCell type specific changes in BMP-7 expression contribute to the progression of kidney disease in patients with obstructive uropathyLefty-1 alleviates TGF-β1-induced fibroblast-myofibroblast transdifferentiation in NRK-49F cellsLow molecular weight fucoidan ameliorates diabetic nephropathy via inhibiting epithelial-mesenchymal transition and fibrotic processes.P311 promotes renal fibrosis via TGFβ1/Smad signaling.Treatment of renal fibrosis by rebalancing TGF-β/Smad signaling with the combination of asiatic acid and naringenin.Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis.Repeated administration of low-dose cisplatin in mice induces fibrosis.TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis.Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis.Protective role of propofol on the kidney during early unilateral ureteral obstruction through inhibition of epithelial-mesenchymal transition.A potential adjuvant chemotherapeutics, 18β-glycyrrhetinic acid, inhibits renal tubular epithelial cells apoptosis via enhancing BMP-7 epigenetically through targeting HDAC2.TGF-β/Smad3 signalling regulates the transition of bone marrow-derived macrophages into myofibroblasts during tissue fibrosisMicroRNA and nephropathy: emerging concepts.Inhibitory Effect of Bone Morphogenetic Protein 4 in Retinal Pigment Epithelial-Mesenchymal TransitionDragon (repulsive guidance molecule RGMb) inhibits E-cadherin expression and induces apoptosis in renal tubular epithelial cells.Inhibition of complement improves graft outcome in a pig model of kidney autotransplantation.Activation of FXR protects against renal fibrosis via suppressing Smad3 expression.PHF14: an innate inhibitor against the progression of renal fibrosis following folic acid-induced kidney injury.MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy.Characterization of miRNA-regulated networks, hubs of signaling, and biomarkers in obstruction-induced bladder dysfunctionCytokine networking of innate immunity cells: a potential target of therapy.
P2860
Q26771232-1C9FF788-444C-4735-9C96-3BAF2AB924B7Q26851198-686D77FF-ED81-4F54-9694-7AC7320AB8E4Q26865356-B0F1FA5B-79D9-47B6-B4BD-96A388505110Q27002171-422F4B22-2785-4BA6-8B45-BC6308250620Q27005788-824DC9CA-3BFD-4B67-A348-77F1B3436FC6Q28070412-4DA67940-7010-4391-8D28-5AA5854EC50CQ28080865-99E375D4-EC7E-4CC3-B56F-740F128B2D05Q33674769-CD8F1473-EADA-4AA1-BCC3-3D67AFD6F6A6Q33706359-B0827B16-524F-4AB8-AF52-E25FAEB2501BQ33840143-E7927258-B4F6-4916-BDAF-AE6C86098C24Q33944185-D7557520-7B41-41FC-8870-C8E497A35F18Q34062853-364A193A-8088-459C-A166-8A7CEF369AAAQ34139895-E519266B-2AC1-400A-A16A-9F117DD39FC2Q34338572-8F17AC4E-B810-423B-9B00-D41A4A586542Q34634172-64AC6C87-86A4-419A-B63C-921E75DC0D65Q34870671-6DC7F48D-27B3-490F-98EF-3CCA1036C911Q35104478-D905E970-CCB4-4ED7-A693-10A992826463Q35172664-8443FD88-8B35-4E77-A3EC-37FABD856B0CQ35802995-F14A0229-2BF6-47DF-B390-D26C73DF3011Q35852034-5617D9E1-11BB-4A43-81A4-1F8244A8CBABQ35981400-12EF7062-BB54-43F5-9D23-1BB4834DD946Q36225834-DA6F7ACF-F3FD-480D-AA73-5BFFE0D99F62Q36330422-6D6AEE1B-FE24-480C-B6A5-F3F74B71B63CQ36545653-DCF8675A-29C3-4F1A-AB5B-89F1AB944B8EQ36589609-20CA8642-3DE9-4E44-B985-7C03486491D0Q36698742-55DDC024-365F-4B93-93D7-5EAC81B95E7AQ36737131-D998CF3B-8107-4B3D-B953-57054B8352C4Q36777632-F7D07DEC-9D51-49C9-8ACE-93166B157DAFQ36841134-A752A403-1DEE-40D0-AB64-BBF532775AAEQ36870776-79285DD7-CEC7-45E2-AA68-183F5F9FE686Q36962418-6CBA3D02-6AF5-4610-8D6E-1429C7B505A3Q37221074-DB0CA3CF-D07A-4457-959C-468640118AD3Q37227950-61C2668F-479A-4A46-98A7-2CFBF107BA84Q37272087-84B63B4D-ED7F-4061-8DBB-EE3C3CADAACDQ37280720-8DF6F5FD-C839-477C-9352-27E32F74E713Q37419118-C630C9A6-A084-42B4-A6D8-B90DE094BCECQ37550306-0C36A2CD-F4A9-4302-B349-BD14D02F8796Q37565264-F6D5E3D7-A550-49C3-A22A-63DD0E27E1BFQ37599555-F53CDAC3-AB32-4C14-9B55-EF0EFB4F0637Q38180799-782804AD-0301-4ACE-A0B7-B77C7A61378E
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Role of the TGF-β/BMP-7/Smad pathways in renal diseases
@ast
Role of the TGF-β/BMP-7/Smad pathways in renal diseases
@en
Role of the TGF-β/BMP-7/Smad pathways in renal diseases
@nl
type
label
Role of the TGF-β/BMP-7/Smad pathways in renal diseases
@ast
Role of the TGF-β/BMP-7/Smad pathways in renal diseases
@en
Role of the TGF-β/BMP-7/Smad pathways in renal diseases
@nl
prefLabel
Role of the TGF-β/BMP-7/Smad pathways in renal diseases
@ast
Role of the TGF-β/BMP-7/Smad pathways in renal diseases
@en
Role of the TGF-β/BMP-7/Smad pathways in renal diseases
@nl
P2860
P3181
P356
P1433
P1476
Role of the TGF-β/BMP-7/Smad pathways in renal diseases
@en
P2093
Arthur C K Chung
Xiao-Ming Meng
P2860
P304
P3181
P356
10.1042/CS20120252
P407
P50
P577
2013-02-01T00:00:00Z